Croatian
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Valtropin (somatropin) - H01AC01

Updated on site: 10-Oct-2017

Naziv lijekaValtropin
ATK šifraH01AC01
Tvarsomatropin
ProizvođačBioPartners GmbH

Valtropin

authorised

 

somatropin

 

This is a summary of the European public assessment report (EPAR) for Valtropin. It explains how the

Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recomm ndations on the conditions of use for Valtropin.

Valtropin is a ‘biosimilar’ medicine. This means that Valtropin is similar to a biological medicine (the

‘reference medicine’) that is already authorised in the European Union (EU) and that Valtropin and the

reference medicine contain the same active substance. The reference medicine for Valtropin is Medicinal

Humatrope. For more inform tion on biosimilar medicines, see the question-and-answer document here.

What is Valtropin used for?

Valtropin is used to treat children in the following situations:

children from two years of age and adolescents who fail to grow because they lack growth hormone (replacement therapy);

Komentari

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Pomoć
  • Get it on Google Play
  • O nama
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    popisanih lijekova na recept